Funding for this research was provided by:
City University of Hong Kong (7005130, 7005284)
Pershing Square Sohn Cancer Research Alliance
National Institutes of Health (R01AI151059)
Bill and Melinda Gates Foundation (OPP1151054)
Alfred P. Sloan Foundation (G-2015-13964)
Research Grants Council of Hong Kong (11215017)
Hong Kong Institute of Data Science (9360163)
Starr Cancer Consortium (I13-0052)
Received: 30 November 2020
Accepted: 21 April 2021
First Online: 5 June 2021
: All participants were fully informed of the details of the study and provided written informed consent. The study was approved by the City University of Hong Kong Human Subjects Ethics Sub-Committee (ref: H001553).
: Not applicable.
: CEM is a co-Founder of Biotia, Inc.